Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • AGM moved and next meeting

    BAWA can’t  accommodate us for our AGM on April 27 so it has been moved to April 26.  The next members’ meeting at BAWA, Southmead Rd, Filton BS34 7RG is on March 8 at 7pm (Directions here). The next coffee morning will be on February 3 (10am to noon) at the Penny Brohn centre, Chapel Pill Lane, Pill, BS20 0HH with possibly a Zoom meeting for those not attending – more later. A Prospect lunch in the spring has been suggested. Watch this space.  Next walks: around Clapton-in-Gordano on April 1 and Ashton Court on October 7.

    Cancer tumours zapped

    Thousands of men with PCa in the UK could be cured with an hour-long operation, doctors hope. The ‘game-changing’ treatment uses electrical currents to destroy difficult-to-reach tumours. The therapy, called Nanoknife, has been dubbed as ‘amazing, simple and quick’ after being found to have fewer side effects. It also reduces risks to surrounding organs. Patients don’t need to stay in overnight after the op. See more here

    Screening in 5 years?

    Screening for PCa could be possible within five years, says a leading UK expert. Prof Ros Eeles, from the Institute of Cancer Research, says advances in genetics and medical imaging were making it possible. NHS England said screening had been notoriously tricky. The PSA test is controversial and the UK’s National Screening Committee does not recommend it (Dec ’21). See more here

    Join registry for info

    PCa Research are seeking men to join a first-of-its-kind registry. It would revolutionise PCa  diagnosis, treatment and care by putting real people at the centre of it all. But joining would not only benefit others. You would also be able to access more relevant information about your treatment and care, be kept informed about the most relevant clinical trials you are eligible for, and provide critical evidence to speed up and shape vital research. Sign up here

    Writing as therapy

    Discover the therapeutic benefits of creative writing in a safe, supported group. Support your wellbeing; find out how being creative can lead to insight, enjoyment and relaxation; meet and share with others in a similar situation to your own. No previous writing experience needed. Referrals on to the creative writing programme are being accepted by North Bristol NHS Trust, with the next programme in February. And there will be more sessions from spring onwards. To find out more and book a place email fresh.arts@nbt.nhs.uk; visit NGS Macmillan Wellbeing Centre Reception; or call Donna Baber, Fresh Arts Manager, on 07554 334 828.

    Webinar on coping postponed

    Postponed: The January 10 Prostate Cancer Research Zoom webinar to help wives, husbands and partners to understand and cope had to be postponed. More later. To sign up for these sessions go to

    Bladder problems?

    A project has been launched to initiate positive change for those affected by bladder and bowel conditions (Nov ’21). See more and register here

    Protein ‘a cancer killer’

    A protein that is said to be able to stop PCa in its tracks has been discovered by US scientists. It could help patients who have become unresponsive to hormone treatmtent. More here

    RaNT video available

    Ryan Edginton recently told us about the Raman Nanotheranostics (RaNT) team who are developing a new, all-in-one technology capable of diagnosing and treating cancers using a single device. See the video here

    PSA tests for some over-40s?

    Some men should have annual prostate checks after 40 to spot early, treatable cancers, UK experts say. Targeted PSA screening would save lives, the Institute of Cancer Research team says, even though that blood test is not accurate enough to offer more widely. The idea was trialled in men at high genetic risk for certain cancers (Oct ’21). More here

    Nutrition and prostate cancer

    A video of the Prostate Cancer Research webinar session on this subject is available on demand here A copy of the presentation is available here  For more information or how to contact the presenters visit here

    Good news for advanced patients

    Apalutamide has been approved, Prostate Cancer UK reports. It means hormone treatment willl now be offered to those with advanced PCa who cannnot or should not receive chemotherapy as well as those who have become resistant to tranditional hormone therapies (Sept ’21).

    Test might detect 50 cancers

    NHS to trial ‘revolutionary’ blood test that can detect 50 types of cancer early (Sept ’21). See here

    Memorial to tour UK

    You can add a loved-one’s name to a Prostate Cancer UK memorial that will soon tour the UK. See how here

    Covid vaccine tech ‘could beat cancer’

    The Oxford-Astra Zeneca Covid vaccine technology has been used to design a jab that could treat cancer (Sept ’21). Sky News

    Enzalutamide (Xtandi) approved

    Important news from NICE for the 4,100 men each year who are unsuitable for the standard treatment of docetaxel chemotherapy and who have, until now, had limited treatment options (June ’21).  More here:

    Study into black men’s higher risk

    In partnership with Movember, Prostate Cancer UK is funding a study to help find out why black men are at higher risk of PCa than other ethnic groups. More here

    New vaccine ‘could prevent PCa’

    See here

    Bone scan breakthrough

    A new bone scan technique can identify men with advanced PCa who’ll benefit from radiotherapy. This ground-breaking achievement could help extend the lives of 25-30% of such patients (Jan ’21). See more here

    Bad news re Olaparib

    Olaparib has given new hope to men with incurable PCa, says the Daily Mail in this article. But in January NICE said it intends to reject olaparib for men in England, Wales and Northern Ireland, just months after it was approved in Scotland. See more here

    Big change in PCa diagnosis

    The biggest diagnostic development in PCa diagnosis for 50 years – that came about when NICE advised that all men at risk of PCa should have an MRI before a biopsy. The change has had a worldwide effect. See more here

    Check your risk in 30 seconds!

    An online 30-second risk checker has been launched which men are encouraged to take –  see here

  • Patient guide ‘good source of info’

    Prostate Cancer Foundation’s Patient Guide (updated to ’21) is said to be one of the best sources of information from diagnosis to survival of PCa. Download it for free here.  Our New Research page is updated regularly.

  • Drugs approved and a PCa ‘killer’

    The NHS confirmed that the chemotherapy drug docetaxel will be made available to PCa patients as soon as they are diagnosed instead waiting until other treatments stop working. See.  And NICE has approved a new drug, Darolutamide, as an option for treating hormone-relapsed PCa in men at high risk of developing metastatic disease. See more here Also scientists have found that a natural insecticide kills advanced PCa cells. See more here More news on the newsletter page.

RunningWe are a friendly and supportive network that meets at BAWA, Filton. Meeting details and directions are in the column on the left.

New chairman and secretary

Tim Bond, below, was elected chairman of Prospect at the 2021 AGM. He replaces Malcolm Gamlin, who retired after 13 years in the role. Malcolm was thanked for his hard work.

Mick Broggio resigned as secretary but volunteer Martin Webb was co-opted by the committee in July and elected at the AGM. Other committee members were re-elected at the AGM too.

Our group aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

We offer a friendly welcome – join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect email prospect.bristol@gmail.com or call the Tackle helpline, which will put you in touch with us: 0800 035 5302. You can join us for a small subscription by filling in the PDF membership form on the Contact/Join us page.

This site has been compiled by PCa survivors. We don’t claim to have specialist knowledge other than that gained by PCa patients during their treatment.

Protected from despair…

George Monbiot writes in the Guardian that the principles that define a good life protect him from despair, despite a diagnosis of prostate cancer and the ‘grisly’ operation he faces (Mar ’18). See here

We give illustrated talks

Our Mike Broxton gives prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 0800 035 5302.

Having the conversation…

“Manversation” is a campaign to encourage men to speak about prostate cancer, particularly the advanced prostate form. Tackle have collaborated with Orchid, the male cancer charity, and put their name to a video and supporting material on the Manversation website.

Myths debunked and spotting fake cancer news

Ten cancer myths debunked. See here. And also here are six tips to spot cancer fake news

New information for at-risk black men

One in four black men will get prostate cancer – double the overall risk faced by all UK men. Are you are risk? See here

Energise wins award

The exercise-based cancer rehab programme Energise won the Together We Achieve award for 2016. The award, announced at the inaugural Health & Care Awards in March ’17, recognises teams working together to deliver improved patient care and public health. See a video about their work here.

For more information on Energise see our Helpful links page.

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See here. The charity also says PCa survival has tripled in the UK over the past 40 years. More than eight in 10 patients are alive ten years after diagnosis – up from one in four in the 1970s.

And we have more research news here.

Swedish test dropped

Swedish researchers found a test which showed promise and seemed much better than PSA alone at detecting potentially dangerous prostate cancers. But now Prostate Cancer UK says the Swedish test, while it has had some uptake in some Scandinavian countries, it has not seen the same uptake elsewhere. Prostate Cancer UK said it had initially intended to support some research towards its use in the UK, but this did not materialise and the field has advanced somewhat since then. It is considering a number of other options which could prove to be more effective than PSA as a diagnostic test, and as specified in its revised research strategy, it is intending large-scale investment to support the development of a screening programme for PCa. The charity hopes to be able to provide an update about this in due course.

Tiger or pussycat? That’s the problem

It’s a big problem to tell the difference between slow-growing cancers and aggressive ones. See here

Cancer ‘as unique as fingerprints’

Each person’s cancer is as unique as their fingerprints, said Professor Gillies McKenna, Director of the CRUK/MCR Oxford Institute for Radiation Oncology. This created an opportunity for more precise treatment.

Back to top

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Exchange information

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Help with treatment choices

    Get enhanced guidance on treatment options, thanks to a checklist developed by researchers (Jun ’17). See. More help here. And why it’s difficult to choose among treatment options (Jul ’17). See. Men with early stage prostate cancer wishing to preserve sexual function while on treatment do not always make the right choices. See

  • Buddies home support update

    This Macmillan service offered support for adult cancer patients in our areas and they have been working on re-starting  face-to-face visits again. The Bristol Buddies service has moved to its national telephone service. Ring 07543 248714 or see this site for support.